DEERFIELD BEACH, Fla., Oct. 27, 2006 (PRIMEZONE) -- Red Reef Laboratories International, Inc. (Pink Sheets: RREF) management is showing concern for the recent spam program inundating investors and institutions recently. Red Reef Labs management disavows the practice and reminds its loyal long term investors that the company's plans for expansion and development have not changed.
Successful testing of Red Reef Labs' core technology against live and weaponized Anthrax, and b subtilis, its surrogate, conducted for and paid for by the U.S. Government, continues to drive and support the company's protocol for surface decontamination; more effective, less toxic ... a better way to deal with our environment.
Recently, Red Reef Labs acquired a strategically important property in Napoleonville, LA, to establish a presence for a full service catastrophe remediation company featuring Red Reef Labs' proprietary decontamination technology as well as the oil spill-soil reclamation technology acquired with the Napoleonville purchase. The plan for near term expansion is to seek and acquire synergistic companies with proven management and track records which will enhance this strategy.
While developing pro-active businesses, Red Reef Labs will continue to develop formulas for EPA and FDA testing and expects to actively market products under its BioClear(tm) trademark that will compete in broad market distribution centers, such as hospital and nursing home indoor environment and air quality, veterinary applications and the sanitization of facilities and equipment used in animal husbandry, to name a few. These same formulas and similar formulas have strong applications for military and homeland defense bio-decontamination and first responder protection.
Forward-Looking Statements
Certain statements in this news release may contain 'forward-looking' information within the meaning of the Federal securities laws. All statements, other than statements of fact, included in this release may include forward-looking statements that may involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances or to reflect unanticipated events or developments.
To access more information, please visit our web site www.rrlabs.biz